Pioneering Fibrin-Targeting Therapies to Treat Inflammatory Neurological and Retinal Diseases

Therini Bio® is developing novel therapeutics based on unique insights into the novel role of fibrin in driving chronic innate immune activation that characterizes a broad set of human diseases with high unmet need.

Dedicated to Patients

We are a world-class team of drug developers who are at the forefront of exploring the breadth and depth of the potential to target fibrin-mediated inflammation. There is a significant unmet need for patients with neurodegenerative and peripheral inflammatory conditions associated with loss of vascular integrity. We are developing novel medicines to treat these diseases in hopes to bring benefit to these patients.